PTH Promethean

3.125

0.00 (0.00%)

23 Jul 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Promethean	LSE:PTH	London	Ordinary Share	GB00B08H5G38	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%	3.125						0.00	01:00:00

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
	0	0		N/A	0

Rule 2.10

09/09/2003 3:14pm

UK Regulatory

RNS Number:5609P
PPL Therapeutics PLC
09 September 2003



Date:               Immediate, Tuesday 9 September 2003

Contact:                Geoff Cook, Chief Executive Officer
                        Lindsay Dunsmuir, Chief Financial Officer
                        PPL Therapeutics plc     Telephone:  0131 440 477



                        Alistair Mackinnon-Musson
                        Philip Dennis
                        Hudson Sandler           Telephone:  020 7796 4133

                                                  Email: ppl@hspr.co.uk









                          PPL Therapeutics plc ("PPL")







In accordance with Rule 2.10 of The City Code on Takeovers and Mergers, PPL
Therapeutics announces that it has 118,582,994 ordinary shares in issue of 1
pence each.



The International Securities Identification Number for PPL Therapeutics ordinary
shares is GB0006657448.









                                    - Ends -






                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

HOLEALNNEFEDEFE